Development Pipeline

Our pipeline is anchored by EFX, a potential best-in-class treatment, if approved, for MASH.

  • PreCli.
  • Ph1
  • Ph2
  • Ph3
  • Program
  • Phase

Efruxifermin (EFX) Efruxifermin (EFX) Pre-cirrhotic MASH (F2-F3)
  • PH3

Efruxifermin (EFX) Efruxifermin (EFX) Compensated Cirrhosis due to MASH (F4)
  • PH3

Research Programs Research Programs Undisclosed Indications
  • Pre-C

EFX is a multi-modal investigational drug that holistically confronts MASH.

Learn About Efruxifermin

EFX is a multi-modal investigational drug that holistically confronts MASH.

Learn About EFX